Alnylam Pharmaceuticals, Inc. (ALNY)

406.18 -9.03 (-2.17%) USD  |  NASDAQ  |  Dec 10, 15:02
More

Alnylam Pharmaceuticals Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Glaukos Corp. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
Revenue (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Gross Profit Margin (Quarterly) Upgrade
Profit Margin (Quarterly) Upgrade
Earnings Yield Upgrade
Operating Earnings Yield Upgrade
Normalized Earnings Yield Upgrade